Faecal concentrations of piperacillin and tazobactam in elderly patients.
Wilcox
M H
MH
Brown
A
A
Freeman
J
J
D000368:Aged; D000369:Aged, 80 and over; D016360:Clostridioides difficile / Q000187:drug effects* / Q000254:growth & development; D004761:Enterocolitis, Pseudomembranous / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000032:analysis*; D005243:Feces / Q000737:chemistry* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000032:analysis*; D010406:Penicillins / Q000032:analysis*; D010878:Piperacillin / Q000009:adverse effects / Q000032:analysis*; D000078142:Tazobactam
D004791:Enzyme Inhibitors; D010406:Penicillins; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin